Evan R. Lewis is Senior Director of Pharmaceutical Development at Kezar Life Sciences. He has over 20 years of small molecule drug development experience including formulation development for the anti-cancer agent, Kyprolis®. Evan holds a Ph.D. in Chemistry from the University of California, Santa Cruz.
Sessions
A3: Technical Challenges and Hot Topics
A3: Q&A for Technical Challenges and Hot Topics